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evaluate the accuracy of a fully automatic approach for QT duration eval-
uation.
 
Methods:
 
 12-lead digital ECG Holter were recorded in 38 healthy sub-
jects (27 males, mean age=27.4±8.0 years) on baseline conditions (day 0)
and after administration of 160 mg (day 1) and 320 mg (day 2) of d-l
Sotalol. For each 24-hour period and each subject, ECGs were extracted
every 10 minutes during the 4-hour period following drug dosage. Ventric-
ular repolarization was characterized using 3 biomarker categories: conven-
tional ECG time intervals, Principal Component Analysis (PCA) analysis on
the T-wave, and fully automatic biomarkers computed from a mathematical
model of the T-wave.
 
Results:
 
 QT interval was significantly prolonged starting 1h20 minutes
after drug dosing with 160 mg and 1h 10 minutes after drug dosing with 320
mg. PCA ventricular repolarization parameters sotalol-induced changes were
delayed (>3 hours). After sotalol dosing, the early phase of the T-wave
changed earlier than the late phase prolongation. Globally, the modeled surro-
gate QT paralleled manual QT changes.
The duration of manual QT and automatic surrogate QT were strongly cor-
related (R
 
2
 
=0.92, p<0.001). The Bland & Altman plot revealed a non-sta-
tionary systematic bias (bias =26.5ms ±1.96*SD = 16ms).
 
Conclusions:
 
 Changes in different ECG biomarkers of ventricular repolar-
ization display different kinetics after administration of a potent potassium
channel blocker. These differences need to be taken into account when
designing ventricular repolarization ECG studies.
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Fine-QRS complex tachycardia alternating with wide-QRS complex tachy-
cardia can lead to an erroneous diagnosis of paroxysmal supraventricular
tachycardia (SVT) with or without aberrancy. The purpose of the study was to
evaluate the incidence and the significance of the association of SVT and ven-
tricular tachycardia (VT) in the same patient.
Population: 898 patients aged from 11 to 88 years were consecutively
admitted for a sustained VT; 818 patients had associated heart disease (history
of myocardial infarction 374, idiopathic dilated cardiomyopathy 69, arrhyth-
mogenic right ventricular dysplasia 86, miscellaneous 289) and 80 had no
apparent heart disease.
Methods: Electrophysiological study including programmed atrial and
ventricular stimulation, 2D cardiac echocardiography, coronary angiography in
patients older than 40 years, right ventricular angiography and cardiac RMI
since 2002, were performed in these patients.
Results: Fifteen patients presented (2 %) with either SVT or VT. All
SVT’s were related to an atrioventricular node reentrant tachycardia
(AVNRT). The association of SVT and VT was significantly more frequent
in patients without heart disease and with verapamil-sensitive VT (n=6/80,
7.5 %)(<0.001), arrhythmogenic heart disease (n=4/86, 5 %)(0.05) than in
those with myocardial infarction (n=4/374, 0.1 %) or dilated cardiomyopathy
(n=0). Among 692 patients with AVNRT, 39 had associated heart disease
and only 5 have both tachycardias. Radiofrequency ablation of AVNRT per-
formed in all patients did not change the recurrence of VT which required
ablation in 3 patients and the implantation of antitachycardia device with
defibrillator in 2 patients.
Conclusion: The association of SVT and VT is rare in patients with heart
disease except in those with arrhythmogenic right ventricular dysplasia. The
association is more frequent in patients without heart disease diagnosis and
could be underestimated; fine QRS complex tachycardia alternating with wide
QRS complex tachycardia leads generally to the erroneous diagnosis of SVT
with or without aberrancy.
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Implantable cardioverter defibrillaror (ICD) is the gold standard therapy for
patients at high risk for ventricular tachyarrhythmias in secondary and primary
prevention.
Patients with an ICD implanted for primary or secondary prevention were
selected from a single-center registry between Jan99-Dec 08. 359 pts (312
men, age 63±12.4years) received consecutively 432 ICD. Among them 217
(60%) have an ischemic heart disease. It was a primary indication in 30%
and a secondary in 70% of cases.72 pts (22%) received one or more appro-
priate shock and 27% efficacy antitachycardia pacing. Secondary indication
(RR=7,8; 95%CI: 2,63-23,25), treatment with amiodarone (RR=2.5; 95%CI:
1.34-4.99) and low left ventricular ejection fraction LVEF (<30%) (RR=1.9;
95% CI: 1.02-3.64) predicted appropriate shock occurrence. There were 63
deaths. Heart failure is the major event for hospitalization and remained the
predominant mode of death. Predictors of mortality in multivariate modeling
included LVEF, increasing age and the use of another treatment than beta-
blocker single use. One or more appropriate shock seems to promote the
mortality.
During the follow up, complication occurred in 33% of cases: one or more
inappropriate shock n =58 (16%), 36 leads dislodgment, 28 haematomas, 8
infections, 7 leads failure, 4 device failure, 2 pneumothorax, 2 subclavian
thrombosis and 7 others.
Prior atrial fibrillation (RR=2.2; 95% CI: 1.12-4.32) and a secondary indi-
cation (RR=2.83; 95% CI: 1.27-6.30) predicted inappropriate shock occur-
rence. The incidence of inappropriate interventions was not dependent on the
type of ICD (VVI vs. DDD).
Conclusions: Infection can be the most important complication, leading to
the system removal. Inappropriate ICD shocks are common adverse conse-
quences that may impair quality of life, may cause hospitalizations and limit
cost-effectiveness. Preventive measures are required to optimize quality of life
of patients with ICD.
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Objective: Automatic algorithms in pacemakers (PM) allow contin-
uous adaptation of settings to patients’ clinical conditions. Some are ded-
icated to pacing and others to sensing. One of the objectives of BELUGA
on-going, international, prospective registry was to evaluate the use of
automatic algorithms available in Insignia™ PM in current medical prac-
tice.
Methods: The percentage (%) of activation of atrio-ventricular search hys-
teresis algorithm (AVSH), dynamic AV delay (DynAVD), automatic atrial/
ventricular sensing (AAS/AVS), ventricular automatic capture (VAC) and the
% of use of automatic ventricular threshold test during patients assessment
